Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Insights into possibilities for grouping and read-across for nanomaterials in EU chemicals legislation.

Mech A, Rasmussen K, Jantunen P, Aicher L, Alessandrelli M, Bernauer U, Bleeker EAJ, Bouillard J, Di Prospero Fanghella P, Draisci R, Dusinska M, Encheva G, Flament G, Haase A, Handzhiyski Y, Herzberg F, Huwyler J, Jacobsen NR, Jeliazkov V, Jeliazkova N, Nymark P, Grafström R, Oomen AG, Polci ML, Riebeling C, Sandström J, Shivachev B, Stateva S, Tanasescu S, Tsekovska R, Wallin H, Wilks MF, Zellmer S, Apostolova MD.

Nanotoxicology. 2019 Feb;13(1):119-141. doi: 10.1080/17435390.2018.1513092. Epub 2018 Sep 5.

PMID:
30182766
2.

Scientific Basis for Regulatory Decision-Making of Nanomaterials Report on the Workshop, 20-21 January 2014, Center of Applied Ecotoxicology, Dübendorf.

Studer C, Aicher L, Gasic B, von Goetz N, Hoet P, Huwyler J, Kägi R, Kase R, Kobe A, Nowack B, Rothen-Rutishauser B, Schirmer K, Schneider G, Vermeissen E, Wick P, Walser T.

Chimia (Aarau). 2015;69(1-2):52-6. doi: 10.2533/chimia.2015.52.

PMID:
26507088
3.

White paper on the promotion of an integrated risk assessment concept in European regulatory frameworks for chemicals.

Wilks MF, Roth N, Aicher L, Faust M, Papadaki P, Marchis A, Calliera M, Ginebreda A, Andres S, Kühne R, Schüürmann G; HEROIC consortium.

Sci Total Environ. 2015 Jul 15;521-522:211-8. doi: 10.1016/j.scitotenv.2015.03.065. Epub 2015 Apr 1.

PMID:
25841074
4.

Scientific Basis for Regulatory Decision-Making of Nanomaterials Report on the Workshop, 20-21 January 2014, Center of Applied Ecotoxicology, Dübendorf.

Studer C, Aicher L, Gasic B, von Goetz N, Hoet P, Huwyler J, Kägi R, Kase R, Kobe A, Nowack B, Rothen-Rutishauser B, Schirmer K, Schneider G, Vermeissen E, Wick P, Walser T.

Chimia (Aarau). 2015 Feb 25;69(1):52-56. doi: 10.2533/chimia.2015.52.

PMID:
28982464
5.

Multiple low-dose challenges in a rhesus macaque AIDS vaccine trial result in an evolving host response that affects protective outcome.

Selinger C, Strbo N, Gonzalez L, Aicher L, Weiss JM, Law GL, Palermo RE, Vaccari M, Franchini G, Podack ER, Katze MG.

Clin Vaccine Immunol. 2014 Dec;21(12):1650-60. doi: 10.1128/CVI.00455-14. Epub 2014 Oct 1.

6.

Deep transcriptional sequencing of mucosal challenge compartment from rhesus macaques acutely infected with simian immunodeficiency virus implicates loss of cell adhesion preceding immune activation.

Barrenas F, Palermo RE, Agricola B, Agy MB, Aicher L, Carter V, Flanary L, Green RR, McLain R, Li Q, Lu W, Murnane R, Peng X, Thomas MJ, Weiss JM, Anderson DM, Katze MG.

J Virol. 2014 Jul;88(14):7962-72. doi: 10.1128/JVI.00543-14. Epub 2014 May 7.

7.

Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury.

Gralinski LE, Bankhead A 3rd, Jeng S, Menachery VD, Proll S, Belisle SE, Matzke M, Webb-Robertson BJ, Luna ML, Shukla AK, Ferris MT, Bolles M, Chang J, Aicher L, Waters KM, Smith RD, Metz TO, Law GL, Katze MG, McWeeney S, Baric RS.

MBio. 2013 Aug 6;4(4). pii: e00271-13. doi: 10.1128/mBio.00271-13.

8.

Perspectives for integrating human and environmental risk assessment and synergies with socio-economic analysis.

Péry AR, Schüürmann G, Ciffroy P, Faust M, Backhaus T, Aicher L, Mombelli E, Tebby C, Cronin MT, Tissot S, Andres S, Brignon JM, Frewer L, Georgiou S, Mattas K, Vergnaud JC, Peijnenburg W, Capri E, Marchis A, Wilks MF.

Sci Total Environ. 2013 Jul 1;456-457:307-16. doi: 10.1016/j.scitotenv.2013.03.099. Epub 2013 Apr 24.

9.

Modeling host genetic regulation of influenza pathogenesis in the collaborative cross.

Ferris MT, Aylor DL, Bottomly D, Whitmore AC, Aicher LD, Bell TA, Bradel-Tretheway B, Bryan JT, Buus RJ, Gralinski LE, Haagmans BL, McMillan L, Miller DR, Rosenzweig E, Valdar W, Wang J, Churchill GA, Threadgill DW, McWeeney SK, Katze MG, Pardo-Manuel de Villena F, Baric RS, Heise MT.

PLoS Pathog. 2013 Feb;9(2):e1003196. doi: 10.1371/journal.ppat.1003196. Epub 2013 Feb 28.

10.

Expression quantitative trait Loci for extreme host response to influenza a in pre-collaborative cross mice.

Bottomly D, Ferris MT, Aicher LD, Rosenzweig E, Whitmore A, Aylor DL, Haagmans BL, Gralinski LE, Bradel-Tretheway BG, Bryan JT, Threadgill DW, de Villena FP, Baric RS, Katze MG, Heise M, McWeeney SK.

G3 (Bethesda). 2012 Feb;2(2):213-21. doi: 10.1534/g3.111.001800. Epub 2012 Feb 1.

11.

Host regulatory network response to infection with highly pathogenic H5N1 avian influenza virus.

Li C, Bankhead A 3rd, Eisfeld AJ, Hatta Y, Jeng S, Chang JH, Aicher LD, Proll S, Ellis AL, Law GL, Waters KM, Neumann G, Katze MG, McWeeney S, Kawaoka Y.

J Virol. 2011 Nov;85(21):10955-67. doi: 10.1128/JVI.05792-11. Epub 2011 Aug 24.

12.

Long-term programming of antigen-specific immunity from gene expression signatures in the PBMC of rhesus macaques immunized with an SIV DNA vaccine.

Belisle SE, Yin J, Shedlock DJ, Dai A, Yan J, Hirao L, Kutzler MA, Lewis MG, Andersen H, Lank SM, Karl JA, O'Connor DH, Khan A, Sardesai N, Chang J, Aicher L, Palermo RE, Weiner DB, Katze MG, Boyer J.

PLoS One. 2011;6(6):e19681. doi: 10.1371/journal.pone.0019681. Epub 2011 Jun 20.

13.

Genomic analysis reveals pre- and postchallenge differences in a rhesus macaque AIDS vaccine trial: insights into mechanisms of vaccine efficacy.

Palermo RE, Patterson LJ, Aicher LD, Korth MJ, Robert-Guroff M, Katze MG.

J Virol. 2011 Jan;85(2):1099-116. doi: 10.1128/JVI.01522-10. Epub 2010 Nov 10.

14.

Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes.

Cillóniz C, Shinya K, Peng X, Korth MJ, Proll SC, Aicher LD, Carter VS, Chang JH, Kobasa D, Feldmann F, Strong JE, Feldmann H, Kawaoka Y, Katze MG.

PLoS Pathog. 2009 Oct;5(10):e1000604. doi: 10.1371/journal.ppat.1000604. Epub 2009 Oct 2.

15.

Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers.

Peng X, Li Y, Walters KA, Rosenzweig ER, Lederer SL, Aicher LD, Proll S, Katze MG.

BMC Genomics. 2009 Aug 11;10:373. doi: 10.1186/1471-2164-10-373.

16.

Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus.

Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, García-Sastre A, Tolnay AE, Albrecht R, Pyles JA, Olson PH, Aicher LD, Rosenzweig ER, Murali-Krishna K, Clark EA, Kotur MS, Fornek JL, Proll S, Palermo RE, Sabourin CL, Katze MG.

Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3455-60. doi: 10.1073/pnas.0813234106. Epub 2009 Feb 13.

17.

The tuberous sclerosis complex regulates trafficking of glucose transporters and glucose uptake.

Jiang X, Kenerson H, Aicher L, Miyaoka R, Eary J, Bissler J, Yeung RS.

Am J Pathol. 2008 Jun;172(6):1748-56. doi: 10.2353/ajpath.2008.070958.

18.

Aberrant beta-catenin signaling in tuberous sclerosis.

Mak BC, Kenerson HL, Aicher LD, Barnes EA, Yeung RS.

Am J Pathol. 2005 Jul;167(1):107-16.

19.

Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors.

Kenerson HL, Aicher LD, True LD, Yeung RS.

Cancer Res. 2002 Oct 15;62(20):5645-50.

20.

Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis.

Aicher LD, Campbell JS, Yeung RS.

J Biol Chem. 2001 Jun 15;276(24):21017-21. Epub 2001 Apr 4.

21.
22.

Expression of the casein kinase 2 subunits in Chinese hamster ovary and 3T3 L1 cells provides information on the role of the enzyme in cell proliferation and the cell cycle.

Li D, Dobrowolska G, Aicher LD, Chen M, Wright JH, Drueckes P, Dunphy EL, Munar ES, Krebs EG.

J Biol Chem. 1999 Nov 12;274(46):32988-96.

23.

Changes in the liver protein pattern of female Wistar rats treated with the hypoglycemic agent SDZ PGU 693.

Arce A, Aicher L, Wahl D, Anderson NL, Meheus L, Raymackers J, Cordier A, Steiner S.

Life Sci. 1998;63(25):2243-50.

PMID:
9870710
24.

New insights into cyclosporine A nephrotoxicity by proteome analysis.

Aicher L, Wahl D, Arce A, Grenet O, Steiner S.

Electrophoresis. 1998 Aug;19(11):1998-2003.

PMID:
9740060
25.

Cyclosporine A-induced decrease in calbindin-D 28 kDa in rat kidney but not in cerebral cortex and cerebellum.

Varela MC, Arce A, Greiner B, Schwald M, Aicher L, Wahl D, Grenet O, Steiner S.

Biochem Pharmacol. 1998 Jun 15;55(12):2043-6.

PMID:
9714326
26.

Hepatocellular effects of cyclosporine A and its derivative SDZ IMM 125 in vitro.

Wolf A, Schramm U, Fahr A, Aicher L, Cordier A, Trommer WE, Fricker G.

J Pharmacol Exp Ther. 1998 Mar;284(3):817-25.

PMID:
9495838
27.

Decrease in kidney calbindin-D 28kDa as a possible mechanism mediating cyclosporine A- and FK-506-induced calciuria and tubular mineralization.

Aicher L, Meier G, Norcross AJ, Jakubowski J, Varela MC, Cordier A, Steiner S.

Biochem Pharmacol. 1997 Mar 7;53(5):723-31. Erratum in: Biochem Pharmacol 1997 Jun 15;53(12):1945.

PMID:
9113092
28.

Cyclosporine A decreases the protein level of the calcium-binding protein calbindin-D 28kDa in rat kidney.

Steiner S, Aicher L, Raymackers J, Meheus L, Esquer-Blasco R, Anderson NL, Cordier A.

Biochem Pharmacol. 1996 Feb 9;51(3):253-8.

PMID:
8573191
29.

Protein variability in male and female Wistar rat liver proteins.

Steiner S, Wahl D, Varela MC, Aicher L, Prieto P.

Electrophoresis. 1995 Oct;16(10):1969-76.

PMID:
8586072
30.

Developmental expression of human microsomal epoxide hydrolase.

Omiecinski CJ, Aicher L, Swenson L.

J Pharmacol Exp Ther. 1994 Apr;269(1):417-23.

PMID:
7513361
31.

Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants.

Hassett C, Aicher L, Sidhu JS, Omiecinski CJ.

Hum Mol Genet. 1994 Mar;3(3):421-8. Erratum in: Hum Mol Genet 1994 Jul;3(7):1214.

32.

Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung.

Omiecinski CJ, Aicher L, Holubkov R, Checkoway H.

Pharmacogenetics. 1993 Jun;3(3):150-8.

PMID:
8334439
33.
35.

Supplemental Content

Loading ...
Support Center